cmAngio® vs VitalRhythm
AI Verdict
Choose cmAngio® if…
Choose cmAngio if your primary objective is to leverage routine mammography screenings for early cardiovascular risk assessment in women. This AI software is ideal for identifying Breast Arterial Calcifications (BAC) on existing images, providing crucial insights into potential cardiac health concerns without requiring additional procedures or radiation. It seamlessly integrates into radiology workflows to enhance proactive patient care and risk stratification.
View cmAngio® →Choose VitalRhythm if…
Choose VitalRhythm if you need continuous, AI-powered monitoring for cardiac arrhythmia detection and analysis, particularly in remote patient monitoring settings. This cloud-based software, integrated with the VitalPatch biosensor, is best suited for ongoing ECG signal analysis to detect various arrhythmias and support non-urgent clinical decision-making for patients requiring extended cardiac surveillance.
View VitalRhythm →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | cmAngio® | VitalRhythm |
|---|---|---|
| Pricing | Paid, out-of-pocket | Unknown |
| Deployment | Cloud-based, integrates with any DICOM-compliant viewer | Cloud-based |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
cmAngio®cmAngio emphasizes 'quick and easy installation (less than an hour)' and compatibility with 'any DICOM-compliant viewer'. This suggests a lower barrier to entry and seamless integration into existing radiology workflows. While VitalRhythm integrates with its own ecosystem, cmAngio's broad compatibility and simple setup give it an edge in general usability.
Clinical Value
TieBoth tools offer significant and distinct clinical value. cmAngio provides early cardiovascular risk assessment by detecting Breast Arterial Calcifications on existing mammograms, a novel application that adds value without additional procedures. VitalRhythm offers continuous, AI-powered detection and analysis of various cardiac arrhythmias, crucial for remote patient monitoring and managing acute/chronic cardiac conditions. The specific value depends on the clinical context and patient population, making a definitive winner difficult.
Pricing & Value
cmAngio®Both tools require contacting the vendor for pricing details, indicating a lack of public transparency. However, cmAngio explicitly mentions 'Limited-time offers for no-cost implementation and service may be available'. This potential for reduced initial costs gives cmAngio a slight advantage in perceived value, even without specific pricing information.
Enterprise Readiness
VitalRhythmBoth tools are FDA-cleared, HIPAA-compliant, and cloud-based. However, VitalRhythm explicitly states 'has_baa: yes', indicating a readily available Business Associate Agreement. cmAngio requires contacting the vendor for BAA details, which could introduce a slight delay or additional step in the procurement process for enterprise clients.
Innovation
TieBoth tools demonstrate significant innovation in their respective fields. cmAngio innovates by repurposing existing mammography data to provide insights into cardiovascular health, identifying a new clinical application for an established diagnostic procedure. VitalRhythm's innovation lies in its integration of AI with wearable biosensor technology for continuous, remote cardiac arrhythmia detection and analysis, advancing remote patient monitoring capabilities. Both represent cutting-edge applications of AI in healthcare.
Support & Docs
VitalRhythmBased on web searches, VitalConnect (VitalRhythm) provides more explicit information regarding its support offerings, including a dedicated 'Support' section on its website with FAQs, user manuals, and mentions of 24/7 technical support for its integrated platform. While CureMetrix (cmAngio) mentions customer support, specific details or publicly available documentation are less prominent.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | cmAngio® | VitalRhythm |
|---|---|---|
| Product Name | cmAngiou00ae | VitalRhythm |
| Company | CureMetrix | VitalConnect |
| Primary Function | AI software for detecting Breast Arterial Calcifications (BAC) on mammograms | AI-powered cloud-based software for continuous cardiac arrhythmia detection and analysis |
| Key Feature 1 | AI-based detection of Breast Arterial Calcifications (BAC) | Cloud-based AI software for arrhythmia detection |
| Key Feature 2 | Processes both Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) exams | Continuous ECG signal analysis |
| Key Feature 3 | Provides visualization of BAC location on a scorecard | Detects various cardiac arrhythmias (e.g., atrial fibrillation, AV block, supraventricular tachycardia, ventricular tachycardia, pauses) |
Videos
Demos, reviews, and walkthroughs featuring cmAngio® and VitalRhythm.
Frequently Asked Questions
More Comparisons
More matchups featuring cmAngio® or VitalRhythm
Backers
Who funded each tool's parent company.